Notice on the expected shortage of Zoloft 50 mg film-coated tablets (sertraline)
The marketing authorisation holder for Zoloft 50 mg film-coated tablets (sertraline), Pfizer Croatia d.o.o., has notified the Agency for Medicinal Products and Medical Devices (HALMED) of the expected shortage of this medicine on the Croatian market. The shortage is due to the active substance, sertraline.
The normalisation of the supply chain with this medicinal product is expected by the end of 2015. There are other authorised medicinal products available with the same active substance on the Croatian market.